A Dual 5α-Reductase Inhibitor Dutasteride Caused Reductions in Vascular Density and Area in Benign Prostatic Hyperplasia

Objectives. Dutasteride, a dual 5α-reductase inhibitor, is used to treat benign prostatic hyperplasia. Nevertheless, its histopathological effects on the morphometrics of blood vessels and glands are still controversial. The aim here was to assess the histopathological effects of dutasteride in case...

Descripción completa

Detalles Bibliográficos
Autores principales: Zaitsu, Masayoshi, Tonooka, Akiko, Mikami, Koji, Hattori, Mami, Takeshima, Yuta, Uekusa, Toshimasa, Takeuchi, Takumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3562692/
https://www.ncbi.nlm.nih.gov/pubmed/23401800
http://dx.doi.org/10.1155/2013/863489

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3562692/
https://www.ncbi.nlm.nih.gov/pubmed/23401800
http://dx.doi.org/10.1155/2013/863489

Ejemplares similares